Skip to main content
SpringerLink
Log in

Allgemeine Aspekte

  • Chapter
Arzneitherapie für Ältere

  • 971 Accesses

Zusammenfassung

Moderne Pharmakotherapie muss im Spannungsfeld zwischen Standardisierung einerseits und Individualisierung andererseits bestehen, will sie den Ansprüchen an eine möglichst optimale Behandlung des einzelnen Patienten genügen. Standardisierung ist erforderlich, um Therapiesicherheit zu gewährleisten und dem behandelnden Arzt verlässliche Anhaltspunkte über den zu erwartenden Nutzen der Therapie zur Verfügung zu stellen. Individualisierung ist aber ebenso essenziell, denn jedes Initiieren einer Pharmakotherapie ist in gewissem Sinne auch ein Einzelexperiment mit nicht vollständig gewissem Ausgang, können doch nie alle individuellen Faktoren a priori berücksichtigt und kalkuliert werden. Die Kenntnisse über Nutzen und Risiko einer Pharmakotherapie stammen in heutiger Zeit nach den Prämissen der evidenzbasierten Medizin aus möglichst gut kontrollierten Studien.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bengtson VL, Schaie KW (Ed) (199) Handbook of theories of aging. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Bugeja G, Kumar A, Banerjee AK (1997) Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 315:1059

    PubMed  CAS  Google Scholar 

  • Calis KA, Young LR (2001) Clinical analysis of adverse drug reactions. In: Atkinson AJ, Daniels CE, Dedrick RL, Grudzinskas CV, Markey SP (Eds) Principles of Clinical Pharmacology. Academic Press , San Diego, pp 319–332

    Google Scholar 

  • Fried LP, Tangen CM, Walston J et al. (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–156

    PubMed  CAS  Google Scholar 

  • Horan MA (1998) Presentation of disease in old age. In: Tallis R, Fillit H, Brocklehurst JC (Eds) Brocklehurst’s textbook of geriatric medicine and gerontology. Livingstone, Edinburgh, pp 201–206

    Google Scholar 

  • Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED (2001) Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286:708–713

    Article  PubMed  CAS  Google Scholar 

  • McElnay JC, McCallion CR (1998) Adherence and the elderly. In: Myers LB, Midence K (Eds) Adherence to treatment in medical conditions. Harwood Academic Publishers, Amsterdam, pp 223–253

    Google Scholar 

  • Nikolaus T, Bach M, Specht-Leible N, Oster P, Schlierf G (1995) The timed test of money counting: a short physical performance test for manual dexterity and cognitive capacity. Age and Aging 24:257–258

    Article  CAS  Google Scholar 

  • Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G (1996) Elderly patients´ problems with medication. An inhospital and follow-up study. Eur J Clin Pharmacol 49:255–259

    Article  PubMed  CAS  Google Scholar 

  • Nikolaus T (1999) Physische Gesundheit. In: Nikolaus T, Pientka L (Eds) Funktionelle Diagnostik. Assessment bei älteren Menschen. Quelle & Meyer, Wiebelsheim, S 2(1)–2(12)

    Google Scholar 

  • Renteln-Kruse W von (Ed) (2004) Medizin des Alterns und des alten Menschen. Steinkopff, Darmstadt

    Google Scholar 

  • Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315:1096–1099

    PubMed  CAS  Google Scholar 

  • Runge M, Rehfeld G (2001) Geriatrische Rehabilitation im therapeutischen Team. Thieme, Stuttgart

    Google Scholar 

  • Sackett DL, Richardson WS, Rosenberg W, Haynes RB (1998) Evidence- based medicine. How to practice & teach EBM. Livingstone, Edinburgh

    Google Scholar 

Literatur

  • Atkin PA, Finnegan TP, Ogle SJ, Shenfield GM (1994) Functional ability of patients to manage medication packaging. A survey of geriatric inpatients. Age Ageing 23:113–116

    Article  PubMed  CAS  Google Scholar 

  • Baumgartner RN, Koehler KM, Gallagher D et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763

    PubMed  CAS  Google Scholar 

  • Beard, K (1992) Adverse reactions as a cause of hospital admission in the aged. Drugs Aging 2:356–367

    Article  PubMed  CAS  Google Scholar 

  • Evans JR, Fletcher AE, Wormald RPL et al. (2002) Prevalence of visual impairment in people aged 75 years and older in Britain: results from MRC trial of assessment and management of older people in the community. Br J Ophthalmol 86:795–800

    Article  PubMed  CAS  Google Scholar 

  • Field TS, Gurwitz JH, Harrold LR et al. (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52:1349–1354

    Article  PubMed  Google Scholar 

  • Fried LP, Tangen CM, Walston J et al. (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156

    PubMed  CAS  Google Scholar 

  • Gurwitz JH, Field TS, Harrold LR et al. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289:1107–1116

    Article  PubMed  Google Scholar 

  • Ioannidis JP, Lau J (2001) Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 285:437–443

    Article  PubMed  CAS  Google Scholar 

  • Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159:413–421

    Article  PubMed  Google Scholar 

  • Kongkaew C, Noyce PR, Ashcroft DM (2008) Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 42(7):1017–1025

    Article  PubMed  Google Scholar 

  • Lawton MP, Brody EM (1969) Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist 9:179–186

    PubMed  CAS  Google Scholar 

  • Lehr U, Thomae H (Hrsg) (1987) Formen seelischen Alterns. Ergebnisse der Bonner Gerontologischen Längsschnittstudie (BOLSA). Enke, Stuttgart

    Google Scholar 

  • Manesse CK, Derkx FHM, Ridder MAJ de, Man in’t Veld AJ, Van Der Cammen TJM (1997) Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional survey. BMJ 315:1057–1058

    Google Scholar 

  • Mayer KU, Baltes PB (Hrsg) (1996) Die Berliner Altersstudie. Akademie-Verlag, Berlin

    Google Scholar 

  • Monette J, Gurwitz JH, Avorn J (1995) Epidemiology of adverse drug events in the nursing home setting. Drugs Aging 7:203–211

    Article  PubMed  CAS  Google Scholar 

  • Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G (1969) Elderly patients´problems with medication. An inhospital and follow-up study. Eur J Clin Pharmacol 1996, 49:255–259

    Google Scholar 

  • Nikolaus T (1999) Physische Gesundheit. In: Nikolaus T, Pientka L (Eds) Funktionelle Diagnostik. Assessment bei älteren Menschen. Quelle & Meyer, Wiebelsheim, S 2(1)–2(12)

    Google Scholar 

  • Pirmohamed M, James S, Meakin S et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18.820 patients. BMJ 329:15–19

    Article  PubMed  Google Scholar 

  • Purser JL, Kuchibhatla MN, Fillenbaum GG, Harding T, Peterson ED, Alexander KP (2006) Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc 54:1674–1681

    Article  PubMed  Google Scholar 

  • Ranganathan VK, Siemionow V, Sahgal V, Yue GH (2001) Effects of aging on hand function. J Am Geriatr Soc 49:1478–1484

    Article  PubMed  CAS  Google Scholar 

  • Rothwell, PM (2005) External validity of randomized controlled trials: »To whom do the results of this trial apply?« Lancet 365:82–93

    Google Scholar 

  • Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J (2002) Admissions by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58:285–291

    Article  PubMed  Google Scholar 

  • Schwabe U, Paffrath D (Hrsg) (2008) Arzneiverordnungsreport. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Statistisches Bundesamt (2008) Statistisches Jahrbuch 2008 http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Navigation/Publikationen/Querschnittsveroeffentlichungen/JahrbuchDownlads,templateId=renderPrint.psml__nnn=true. Gesehen 12.2.2009

  • Van Der Pols JC, Bates CJ, Thompson JR, Reacher M, Prentice A, Finch S (2000) Visual acuity measurements in a national sample of British elderly people. Br J Ophthalmol 84:165–170

    Article  PubMed  Google Scholar 

  • Wahl HW, Wetzler R (1998) Möglichkeiten und Grenzen selbständiger Lebensführung in Privathaushalten. Integrierter Bericht zum gleichnamigen Forschungsverbundprojekt. Kohlhammer, Stuttgart

    Google Scholar 

  • Weyerer S, Ding-Greiner C, Marwedel U, Kaufelder T (2008) Epidemiologie körperlicher Erkrankungen und Einschränkungen im Alter. Kohlhammer, Stuttgart

    Google Scholar 

  • Winter LJM de, Hoyng CB, Froeling PGAM, Meulendijks CFM, Van Der Wilt GJ (2004) Prevalence of remediable disability due to low vision among institutionalized elderly people. Gerontology 50:96–101

    Article  PubMed  Google Scholar 

  • WHO (World Health Organization)(2001) Interntional Classification of functioning, disability and health. Genf. http://www.who.int/classifications/icf/en/. Gesehen 6.11.2009

  • Wurm S (2003) Gesundheit in der zweiten Lebenshälfte. Veränderung im Längsschnitt über einen Zeitraum von sechs Jahren. Deutsches Zentrum für Altersfragen, Berlin

    Google Scholar 

Literatur

  • Abernethy DR, Schwartz JB, Plachetka JR et al. (1987) Comparison in young and elderly patients of pharmacodynamics and disposition of labetolol in systemic hypertension. Am J Cardiol 60:697–702

    Article  PubMed  CAS  Google Scholar 

  • Ammon HPT (1991) Grundlagen der Arzneimittelwechselwirkungen. In: HPT Ammon (Hrsg) Arzneimittelneben- und -wechselwirkungen. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 76–90

    Google Scholar 

  • Bertilsson L, Dahl ML, Ingelman-Sundberg M, Johansson I, Sjöqvist F (1995) Interindividual and interethnic differences in polymorphic drug oxidation – implication for drug therapy with focus on psychoactive drugs. In: G Pacifici, GN Fracchia (Hrsg) Advances in drug metabolism in man. EUR 15439 EN, EC, DGXII-E-4. Office for Publication of the European Commission, Luxembourg, pp 85–136

    Google Scholar 

  • Burkhardt, H., Wehling, M., Gladisch, R (2007) Prävention unerwünschter Arzneimittelwirkungen bei älteren Patienten. Z Gerontol Geriatr 40:241–254

    Article  PubMed  CAS  Google Scholar 

  • Campion EW, Avorn J, Reder VA, Olins NJ (1987) Overmedication of the low-weight elderly. Arch Intern Med 147(5):945–947

    Article  PubMed  CAS  Google Scholar 

  • Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572

    Article  PubMed  CAS  Google Scholar 

  • Chen S, Chou WH, Blouin RA et al. (1996) The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. Clin Pharmacol Ther 60:522–534

    Article  PubMed  CAS  Google Scholar 

  • Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41

    Article  PubMed  CAS  Google Scholar 

  • Delafuente JC (2003) Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 48(2):133–143

    Article  PubMed  Google Scholar 

  • Feuring, M., Wehling, M., Falkenstein, E (2000) Beeinflussung der Arzneimittelwirkung durch Erbfaktoren und Erkrankungen. Internist 41:332–337

    Article  PubMed  CAS  Google Scholar 

  • Goeptar AR, Scheerens H, Vermeulen NP (1995) Oxygen and xenobiotic reductase activities of cytochrome P450. Crit Rev Toxicol 25:25–65

    Article  PubMed  CAS  Google Scholar 

  • Levey AS, Bosch JP, Lewis JB et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130:461–470

    PubMed  CAS  Google Scholar 

  • Lewis DF, Watson E, Lake BG (1998) Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics. Mutat Res 410:245–270

    Article  PubMed  CAS  Google Scholar 

  • Lindeman RD (1993) Assessment of renal function in the old: special considerations. Clin Lab Med 13:269–277

    PubMed  CAS  Google Scholar 

  • Podrazik PM, Schwartz JB (1999) Cardiovascular pharmacology of aging. Cardiol Clin 17:17–34

    Article  PubMed  CAS  Google Scholar 

  • Rowe JW, Andres R, Tobin JD et al. (1976) The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155–163

    PubMed  CAS  Google Scholar 

  • Wormhoudt LW, Commandeur JN, Vermeulen NP (1999) Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29:59–124

    Article  PubMed  CAS  Google Scholar 

  • Zeeh J, Platt D (2002) The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 48:121–127

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Beckett NS, Peters R, Fletcher AE et al. (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358(18):1887–1898

    Article  PubMed  CAS  Google Scholar 

  • Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 157:1531–1536

    Article  PubMed  CAS  Google Scholar 

  • Döser S, Marz W, Reinecke MF et al. (2004) Empfehlungen zur Statintherapie im Alter, Daten und Konsensus. Internist 45,1053–1062

    Article  PubMed  Google Scholar 

  • Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH (2007) Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc 55:271–276

    Article  PubMed  Google Scholar 

  • Holt S, Schmiedl S, Thürmann PA (2010) Potenziell inadäquate Medikation für ältere Menschen: Die PRISCUS-Liste. Dtsch Arztebl Int 107:543–551

    PubMed  Google Scholar 

  • Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287:337–344

    Article  PubMed  Google Scholar 

  • Kvan E, Pettersen KI, Landmark K, Reikvam A, INPHARM study investigators (2006) Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention. Pharmacoepidemiol Drug Saf 15(4):261–267

    Article  PubMed  CAS  Google Scholar 

  • Mancia G, De Backer G, Dominiczak A et al. (2007) 2007 ESH– ESC Practice Guidelines for the Management of Arterial Hypertension: ESH–ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25(9):1751–1762

    Article  PubMed  CAS  Google Scholar 

  • Pugh MJ, Hanlon JT, Zeber JE, Bierman A, Cornell J, Berlowitz DR (2006) Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm 12:537–545

    PubMed  Google Scholar 

  • Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (2007) Evidence based medicine: what it is and what it isn’t, 1996. Clin Orthop Relat Res 455:3–5

    PubMed  Google Scholar 

  • Shepherd J, Blauw GJ, Murphy MB et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360:1623–1630

    Article  PubMed  CAS  Google Scholar 

  • Steinman MA, Landefeld CS, Rosenthal GE, Berthental D, Sen S, Kaboli PJ (2006) Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54:1516–1523

    Article  PubMed  Google Scholar 

  • Wehling, M (2008) Arzneimitteltherapie im Alter: Zu viel und zu wenig, was tun? Dtsch Med Wochenschr 133, 2289–2291

    Article  CAS  Google Scholar 

  • Van Den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA (1998) Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 51:367–375

    Article  PubMed  Google Scholar 

  • Zhan C, Sangl J, Bierman AS et al. (2001) Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 286: 2823–2829

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Pharmakologie Mannheim Medizinische Fakultät Mannheim, Universität Heidelberg, Maybachstraße 14, 68169, Mannheim

    Prof. Dr. med. Martin Wehling

  2. Medizinischen Klinik (Schwerpunkt Geriatrie), Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1–3, 68167, Mannheim

    Priv.-Doz. Dr. med. Heinrich Burkhardt

Authors
  1. Prof. Dr. med. Martin Wehling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priv.-Doz. Dr. med. Heinrich Burkhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wehling, M., Burkhardt, H. (2011). Allgemeine Aspekte. In: Arzneitherapie für Ältere. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17308-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-17308-0_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-17307-3

  • Online ISBN: 978-3-642-17308-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation